Nightstar targets $86.3m in IPO
The Oxford University spinout, launched in 2014, files plans with the SEC to go public on the NASDAQ.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
The Oxford University spinout, launched in 2014, files plans with the SEC to go public on the NASDAQ.
In Q2 2017, Oxford companies raised £93m, OUI was named TTO of the Year, and the £1.2bn contribution to the global economy from Oxford's commercialisation capabilities was highlighted in a new report.
The Oxford University AI company secures £17m as it unveils three AI-driven platforms.
The Oxford University company secures £2.3m in Series A funding to translate image management platform for the consumer market.
Scenic Biotech, an international collaboration between Oxford University and Netherlands Cancer Institute, aims to unlock genetic potential in tackling cancer and other diseases with new funding.
Colwiz, a 2013 OUI Incubator company, and Oxford Gene Technology, a spinout 20 years in the making, both make successful trade sales.
The Oxford spinout partners Boehringer on new initiative to combat one of Europe’s biggest killers.
Roundup of news, deals, and data from OUI for Q1 2017.
The Oxford University spinout leads newly formed DRIVEN consortium in most ambitious autonomous vehicle trials worldwide to date.
Spinout Oxford Cancer Biomarkers announces strategic collaboration with My-BioMed Biotechnology Co. Ltd, providing precision medicine to clinicians and patients in China